Results 201 to 210 of about 344,012 (256)

Association of HLA-DQA1*06:01 and DPB1*05:01:01G alleles with susceptibility to end-stage liver disease with HBV infection in liver transplant recipients from the Zhejiang Han population, China. [PDF]

Front Immunol
Lu G, He Y, Lu Y, Chen W, Lu C, Zhu F.
europepmc   +1 more source

Physiology and health assessment, risk balance, and model for end-stage liver disease scores: Postoperative outcome of liver transplantation. [PDF]

World J Transplant
Hohenreuther R, Silveira AT, Filho EMR, Garcez A, Lacerda BG, Fernandes SA, Marroni CA.   +6 more
europepmc   +1 more source

Prognostic value of the modified Model for End-Stage Liver Disease score in patients treated with cardiac resynchronization therapy. [PDF]

Heart Rhythm O2
Long T, Yu Y, Cheng S, Huang H, Hua W.
europepmc   +1 more source

Evaluation of the prognosis of hepatitis B virus-associated acute-on-chronic liver failure patients using a combined model for end-stage liver disease score with blood ammonia, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase. [PDF]

Medicine (Baltimore)
Wang Y, Chen L, Sun W, Li W, Xu Y, Gu J, Gan J.   +6 more
europepmc   +1 more source

Complications of end-stage liver disease.

Canadian family physician Medecin de famille canadien, 2016
Giulia-Anna, Perri, Houman, Khosravani
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

End-stage liver disease complications

Current Opinion in Gastroenterology, 2013
Chronic liver disease causes significant morbidity and mortality because of any number of complications including hepatic encephalopathy, ascites, hepatorenal syndrome (HRS), and esophageal variceal hemorrhage (EVH).Predictors of response to lactulose, probiotics, and L-ornithine-L-aspartate therapy in minimal hepatic encephalopathy (MHE) have been ...
Robert S, Rahimi, Don C, Rockey
openaire   +2 more sources

Prognostic models in end stage liver disease

Best Practice & Research Clinical Gastroenterology, 2023
Cirrhosis is a major cause of death worldwide, and is associated with significant health care costs. Even if milestones have been recently reached in understanding and managing end-stage liver disease (ESLD), the disease course remains somewhat difficult to prognosticate.
Ferrarese, A, Bucci, M, Zanetto, A, Senzolo, M, Germani, G, Gambato, M, Russo, F P, Burra, P   +7 more
openaire   +2 more sources

Nutrition in end stage liver disease

Best Practice & Research Clinical Gastroenterology, 2006
This chapter will focus on studies within the last 5 years of nutrition in end stage liver disease, but earlier studies illustrating the present state of affairs will also be mentioned. The first part will focus on descriptive epidemiological studies that help to set the scene for the intervention studies, which will be described in the second part ...
openaire   +3 more sources

Infectious Diseases in End-Stage Liver Disease Patients

Critical Care Nursing Clinics of North America, 2010
Patients with chronic liver diseases sustain impairment to immune systems, which worsens over time. These defects in their host defense lead to risks of bacterial infections and increased morbidity. Providers should have heightened surveillance for infectious diseases and suspect one with any acute change in status.
Aneesh K, Mehta, G Marshall, Lyon
openaire   +2 more sources

Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40

Hepatology, 2023
Background and Aims: Since the implementation of the model for end‐stage liver disease (MELD) score to determine waitlist priority for liver transplant (LT) in 2002, the score has been capped at 40. Recently, the MELD 3.0 score was proposed to improve upon MELD‐Na. Here, we examine waitlist mortality and LT outcomes in patients
W. Ray Kim, Ajitha Mannalithara, Paul Y. Kwo, C. Andrew Bonham, Allison Kwong   +4 more
openaire   +2 more sources